{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:54:29Z","timestamp":1791136469661,"version":"4.1.0"},"reference-count":82,"publisher":"American Society for Microbiology","issue":"24","license":[{"start":{"date-parts":[[2002,12,15]],"date-time":"2002-12-15T00:00:00Z","timestamp":1039910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2002,12,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The Epstein-Barr virus (EBV) immediate-early protein BZLF1 mediates the switch between the latent and lytic forms of EBV infection and has been previously shown to induce a G\n            <jats:sub>1<\/jats:sub>\n            \/S block in cell cycle progression in some cell types. To examine the effect of BZLF1 on cellular gene expression, we performed microarray analysis on telomerase-immortalized human keratinocytes that were mock infected or infected with a control adenovirus vector (AdLacZ) or a vector expressing the EBV BZLF1 protein (AdBZLF1). Cellular genes activated by BZLF1 expression included E2F-1, cyclin E, Cdc25A, and a number of other genes involved in cell cycle progression. Immunoblot analysis confirmed that BZLF1 induced expression of E2F-1, cyclin E, Cdc25A, and stem loop binding protein (a protein known to be primarily expressed during S phase) in telomerase-immortalized keratinocytes. Similarly, BZLF1 increased expression of E2F-1, cyclin E, and stem loop binding protein (SLBP) in primary tonsil keratinocytes. In contrast, BZLF1 did not induce E2F-1 expression in normal human fibroblasts. Cell cycle analysis revealed that while BZLF1 dramatically blocked G\n            <jats:sub>1<\/jats:sub>\n            \/S progression in normal human fibroblasts, it did not significantly affect cell cycle progression in primary human tonsil keratinocytes. Furthermore, in EBV-infected gastric carcinoma cells, the BZLF1-positive cells had an increased number of cells in S phase compared to the BZLF1-negative cells. Thus, in certain cell types (but not others), BZLF1 enhances expression of cellular proteins associated with cell cycle progression, which suggests that an S-phase-like environment may be advantageous for efficient lytic EBV replication in some cell types.\n          <\/jats:p>","DOI":"10.1128\/jvi.76.24.12543-12552.2002","type":"journal-article","created":{"date-parts":[[2002,11,18]],"date-time":"2002-11-18T23:44:09Z","timestamp":1037663049000},"page":"12543-12552","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":53,"title":["The Epstein-Barr Virus Immediate-Early Protein BZLF1 Induces Expression of E2F-1 and Other Proteins Involved in Cell Cycle Progression in Primary Keratinocytes and Gastric Carcinoma Cells"],"prefix":"10.1128","volume":"76","author":[{"given":"Amy","family":"Mauser","sequence":"first","affiliation":[{"name":"Lineberger Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Holley-Guthrie","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Zanation","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendall","family":"Yarborough","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center"},{"name":"Department of Otolaryngology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center"},{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloysius","family":"Klingelhutz","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Iowa, Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Seaman","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Kenney","sequence":"additional","affiliation":[{"name":"Lineberger Comprehensive Cancer Center"},{"name":"Department of Medicine"},{"name":"Department of Immunology and Microbiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599-7295"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.3.1224-1233.2000"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9396"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)02114-7"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.10.8105-8114.1998"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1689075"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.34.22075"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8489"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0516"},{"key":"e_1_3_1_10_2","first-page":"1413","volume":"13","year":"1996","unstructured":"Cannell, E. J., P. J. Farrell, and A. J. Sinclair. 1996. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells. Oncogene 13 : 1413-1421.","journal-title":"Oncogene"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.17.8028-8037.2000"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.50.31799"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1996.tb00635.x"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.7.3358-3369.1990"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.7.4695"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1986.tb04635.x"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.12.4085"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.1.313-321.1990"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.8.4215"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.2.1629-1634.1997"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.15.2245"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.0147"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03356.x"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65025-0"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-842X(00)01742-X"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.3.1227-1232.1990"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.2.922-929.1992"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05493.x"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1994.tb06584.x"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.10.8245-8255.1999"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.8.3753-3759.1990"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.5.2400-2410.2001"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.11.6697-6704.1995"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)02113-5"},{"key":"e_1_3_1_35_2","first-page":"1105","volume":"8","year":"1997","unstructured":"Kaufmann, W. K., J. L. Schwartz, J. C. Hurt, L. L. Byrd, D. A. Galloway, E. Levedakou, and R. S. Paules. 1997. Inactivation of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts expressing human papillomavirus type 16 E6. Cell Growth Differ. 8 : 1105-1114.","journal-title":"Cell Growth Differ."},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.10.7328-7336.1997"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.9.3878-3883.1989"},{"key":"e_1_3_1_38_2","unstructured":"Kieff E. 1996. Epstein-Barr virus and its replication p. 2343-2395. In B. N. Fields D. N. Knipe and P. M. Howley (ed.) Fields virology. Lippincott-Raven Publishers Philadelphia Pa."},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2491-2500.1995"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.7.3040-3050.1989"},{"key":"e_1_3_1_41_2","first-page":"1833","volume":"15","year":"2001","unstructured":"Lin, W. C., F. T. Lin, and J. R. Nevins. 2001. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15 : 1833-1844.","journal-title":"Genes Dev."},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.18.6848"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.11.9456-9467.1999"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.12.8850-8857.1996"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/7.3.251"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00226-6"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.15.7108-7118.2000"},{"key":"e_1_3_1_48_2","first-page":"585","volume":"9","year":"1998","unstructured":"Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9 : 585-593.","journal-title":"Cell Growth Differ."},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2001.iep190.x"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.5.2110-2116.1990"},{"key":"e_1_3_1_51_2","first-page":"2541","volume":"13","year":"1996","unstructured":"Parker, G. A., T. Crook, M. Bain, E. A. Sara, P. J. Farrell, and M. J. Allday. 1996. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13 : 2541-2549.","journal-title":"Oncogene"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203327"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80387-1"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.7867-7877.1996"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/21.8.1999"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.12.9858-9866.1999"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(75)80001-8"},{"key":"e_1_3_1_58_2","unstructured":"Rickinson A. B. and E. Kieff. 1996. Epstein-Barr virus p. 2397-2446. In B. N. Fields D. M. Knipe and P. M. Howley (ed.) Fields virology. Lippincott-Raven Publishers Philadelphia Pa."},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.11.9029-9038.1999"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.10.4482-4489.2001"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.7.3109-3116.1989"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.5.3729-3741.1998"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90636-5"},{"key":"e_1_3_1_64_2","first-page":"3689","volume":"60","year":"2000","unstructured":"Sherr, C. J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60 : 3689-3695.","journal-title":"Cancer Res."},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-6-1553"},{"key":"e_1_3_1_66_2","first-page":"1122","volume":"2","year":"1986","unstructured":"Sixbey, J. W., S. M. Lemon, and J. S. Pagano. 1986. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 2 : 1122-1124.","journal-title":"Lancet"},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198405103101905"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.0146"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.6.4678-4688.1999"},{"key":"e_1_3_1_70_2","first-page":"699","volume":"8","year":"1997","unstructured":"Spitkovsky, D., A. Schulze, B. Boye, and P. Jansen-Durr. 1997. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Cell Growth Differ. 8 : 699-710.","journal-title":"Cell Growth Differ."},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2613.2001.00165.x"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.8.6540-6550.1999"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9969(79)90099-2"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.57.3.1016-1022.1986"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb03527.x"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.9.6379"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.16.7610-7618.2000"},{"key":"e_1_3_1_78_2","first-page":"1485","volume":"59","year":"1999","unstructured":"Westphal, E. M., A. Mauser, J. Swenson, M. G. Davis, C. L. Talarico, and S. C. Kenney. 1999. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo. Cancer Res. 59 : 1485-1491.","journal-title":"Cancer Res."},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.12.4188-4198.2000"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/20.5.1086"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.10.8043-8051.1998"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.17.9194"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.3.1929-1938.1994"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.76.24.12543-12552.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.76.24.12543-12552.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T07:34:14Z","timestamp":1646465654000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.76.24.12543-12552.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,15]]},"references-count":82,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2002,12,15]]}},"alternative-id":["10.1128\/JVI.76.24.12543-12552.2002"],"URL":"https:\/\/doi.org\/10.1128\/jvi.76.24.12543-12552.2002","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,15]]},"assertion":[{"value":"2001-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-09-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}